Retrospective multicenter clinical study of Conversion rate of hydromorphone in cancer patients
Not Applicable
Recruiting
- Conditions
- cancer
- Registration Number
- JPRN-jRCT1040220043
- Lead Sponsor
- akamura Kazuyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inpatients who changed the route of hydromorphone from injectable to oral
Exclusion Criteria
(1)Patients treated with chemotherapy or radiotherapy in the 24 hours before and after rerouting
(2)Patients who were using opioids other than hydromorphone
(3)Patients with difficulty in pain assessment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The conversion ratio from intravenous hydromorphone to oral hydromorphone
- Secondary Outcome Measures
Name Time Method Factors affecting conversion ratios